yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..

the presumptive leader is not defined, which leads to uncertainty and delays when leadership and action is needed,'' the report says...

�defending the crown� is another way to put it. the king may make mistakes, he may commit heinous offenses, but he is the king, and therefore his position must remain secure..

stephen silberstein, md, director, jefferson university headache center..

in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.